OTLK Insider Trading Activity

Transactions disclosed by company insiders to the SEC on Form 4, most recent first.

InsiderRoleDateSharesValue
Jahr Robert Charles Chief Executive Officer 2026-08-14 151,515 $0
KENYON LAWRENCE A Chief Financial Officer 2026-08-14 101,010 $0
Sukhtian Ghiath M. Insider 2026-08-12 2,525,252 $2,499,999
Sukhtian Faisal Ghiath Director 2026-07-29 95,398 $99,996

How Institutional Funds Moved on OTLK

Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.

FundChangeQuarter
VANGUARD CAPITAL MANAGEMENT LLC VANGUARD CAPITAL MANAGEMENT LLC increased this position by 1617% ($405,235 -> $6,959,226). 2026-06-30
PERCEPTIVE ADVISORS LLC PERCEPTIVE ADVISORS LLC opened a new position worth $4,991,353. 2026-06-30
GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC increased this position by 1434% ($103,392 -> $1,586,044). 2026-06-30
VANGUARD FIDUCIARY TRUST CO VANGUARD FIDUCIARY TRUST CO increased this position by 2793% ($36,365 -> $1,052,046). 2026-06-30
ARMISTICE CAPITAL, LLC ARMISTICE CAPITAL, LLC exited a position previously worth $857,774. 2026-06-30
SIMPLEX TRADING, LLC SIMPLEX TRADING, LLC increased this position by 1094% ($27,302 -> $325,970). 2026-06-30
NORTHERN TRUST CORP NORTHERN TRUST CORP increased this position by 2623% ($13,869 -> $377,722). 2026-06-30
CANTOR FITZGERALD, L. P. CANTOR FITZGERALD, L. P. opened a new position worth $357,750. 2026-06-30

Which Funds Hold OTLK

Largest reported positions as of 2026-06-30.

FundValueShares
VANGUARD CAPITAL MANAGEMENT LLC $6,959,226 4,376,872
PERCEPTIVE ADVISORS LLC $4,991,353 3,139,216
GEODE CAPITAL MANAGEMENT, LLC $1,586,044 997,436
VANGUARD FIDUCIARY TRUST CO $1,052,046 661,664
Sanctuary Advisors, LLC $547,801 344,529
GROUP ONE TRADING LLC $391,821 246,428
NORTHERN TRUST CORP $377,722 237,561
CANTOR FITZGERALD, L. P. $357,750 225,000
SIMPLEX TRADING, LLC $325,970 205,013
JANE STREET GROUP, LLC $277,137 174,300

Data compiled from public SEC filings. This is informational reporting, not investment advice.

Outlook Therapeutics Insider Buys $2.5M in OTLK at $0.99

Illustration of an SEC Form 4 filing document with a stock chart for Outlook Therapeutics (OTLK)

A newly filed Form 4 shows Ghiath M. Sukhtian, an insider at Outlook Therapeutics, Inc. (OTLK), made a substantial open-market purchase of company stock. According to the filing, the transaction was dated August 12, 2026, and involved the purchase of 2,525,252 shares at a price of $0.99 per share, for a total outlay of $2,499,999.48. … Read more